Home

New Mountain Investments II, LLC

CIK 1415950 · last filed 2015-02-23

New Mountain Investments II, LLC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2008. The most recent filing shows the insider bought $102.7M of BLPH on Feb 23, 2015. Across all open-market trades the lifetime net is +$103.3M, making them a net buyer over the disclosed history. The firm reports its address in New York, NY. 11 SEC filings were submitted jointly with STEVEN B KLINSKY.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

2

Lifetime Open-Market Net

$103.31M

Filer Profile

Reported Address
787 SEVENTH AVENUE
49TH FLOOR
NEW YORK, NY 10019
Phone
(212) 720-0300
State of Incorporation
DE
Related Filers
STEVEN B KLINSKY — 11 joint filings, latest 2021-03-22
New Mountain Capital, L.L.C. — 11 joint filings, latest 2021-03-22
Allegheny New Mountain Partners L P — 10 joint filings, latest 2015-02-23
New Mountain Affiliated Investors II LP — 10 joint filings, latest 2015-02-23
BNP PARIBAS SECURITIES CORP — same reported address
HORIZON BIOMEDICAL VENTURES LLC — same reported address
Knightspoint Partners LLC — same reported address
NEW MOUNTAIN VANTAGE GP, L.L.C. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Bellerophon Therapeutics, Inc. (BLPH) Delisted 10%+ Owner 323,992 $0.01 $3.9K $102.74M 1 2015-02-23
DELTEK, INC (PROJ) Delisted 10%+ Owner 25,281,624 — — $570.4K 1 2008-12-01

Recent Filings

2 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-02-23 Bellerophon Therapeutics, Inc. (BLPH) Delisted Buy (P) +8,561,328 $102.74M EDGAR
2008-12-01 DELTEK, INC (PROJ) Delisted Buy (P) +120,564 $570.4K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.